Repligen | RGEN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agilent USD 39.08B 6.43B 2026-06
Align Technology USD 10.33B 1.75B 2026-09
Bio Techne USD 11.44B 79M 2026-11
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Bruker USD 9.68B 181M 2026-11
Charles River Laboratories USD 16.69B 2.7B 2026-11
Danaher USD 157.81B 18.96B 2026-09
Dentsply International USD 2.09B 326M 2026-11
General Electric Aerospace USD 324.02B 65.91B 2026-09
Henry Schein USD 11.26B 1.64B 2026-11
Illumina USD 37.12B 3.64B 2026-11
IQVIA Holdings USD 48.06B 3.81B 2026-11
Mettler Toledo International USD 36.07B 5.79B 2026-11
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 165.12B 1.71B 2026-11
Repligen USD 9.74B 1.1B 2026-11
Revvity USD 19.52B 2.61B 2026-11
Standard Biotools USD 227M 95M 2026-11
Thermo Fisher Scientific USD 249.58B 58.93B 2026-09
Waters USD 27.52B 14.26B 2026-11
West Pharmaceutical Services USD 26.09B 730M 2026-09